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Conclusion: Our results suggest a lack of sympatho-vagal balance activation
in the first 5 min of tilt test in subjects with vasovagal syncope. CI and VD syn-
cope groups show a lower decrease of HF indices in the Early5. Moreover, CI
group shows a lower increase of LF indices. A perspective of this work is the
set of cut-off values from data recorded over the first 5 min of tilt test to esti-
mate the risk and the type of vasovagal reaction, based on a bigger population.
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The effect of n-3 polyunsaturated fatty acids in the pulmonary circulatory
is not well defined. This question is clinically relevant in respiratory failure
associated with pulmonary hypertension. To investigate this effect we have
realised a randomized, placebo-controlled comparative study on sixty-two
chronically prepared lamb fetuses.
Methods: Catheters and ultrasonic flow transducer were placed through a
left thoracotomy in the lamb fetus to determine aortic, pulmonary, and left
atrial pressures and left pulmonary artery blood flow. We compared the pul-
monary vascular responses to 120 min of Omegaven (lipid emulsions enriched
in n-3 polyunsaturated fatty acids) or Intralipide (lipid emulsions enriched in
n-6 polyunsaturated fatty acids) infusion. Then we investigated the effects of
Omegaven on the pulmonary circulation after nitric oxide synthase inhibition
by L-nitro-arginine, potassium channel blockade by tetraethylammonium,
cytochrome P450 epoxygenase inhibition by (methylsulfonyl)-2- (2-propyny-
loxy)-benzenehexanamide, and cyclo-oxygenase inhibition by Ibuprofen.
Results: Pulmonary artery and aortic pressures as well as blood gases and
plasma lactate concentrations did not change during either fat emulsion infusion.
Left pulmonary blood flow increased by 30% and pulmonary vascular resistance
decreased by 28% during Omegaven infusion, whereas they did not change during
Intralipide infusion. This pulmonary vascular response to Omegaven was not
altered by l-nitro-arginine or Ibuprofen infusion. At the opposite, Omegaven
induced pulmonary vasodilatation was abolished by tetraethylammonium and
markedly attenuated by (methylsulfonyl)-2- (2-propynyloxy)-benzenehexanamide.
Conclusion: Lipid emulsion containing n-3 polyunsaturated fatty acids
may induce a potent and sustained vasodilatation in the fetal lung. This pul-
monary vasodilator response is mediated through production of vasoactive
mediators by cytochrome P450 epoxygenase and through activation of potas-
sium channels.
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Background and objectives: Recent data have shown that phospholipids
(mainly phosphatidylcholine) transfer activity is associated to metabolic syn-
drom and coronary artery disease (CAD). This transfer activity could modu-
late the phosphatidylcholine (PC) distribution between lipoprotein subclasses.
In this study we separated lipoprotein fractions and we analyzed PC distribu-
tion.
Methods: Ninety two subjects were recruited (47 CAD patients and
45 age- and sex- matched controls). Antropometric measurements, lipid pro-
file and PC analysis were performed.
Results: Despite from an abnormal lipid profile: elevated serum trigly-
cerides and LDL-C, and low HDL-C (but total cholesterol level was not
significantly different between controls and CAD patients), serum PC centra-
tions were slightly higher in CAD patients than in controls (respectively
2.53±0.84 and 2.36±0.43 mmol/L, ns). The level of PC was significanly
higher in patients, compared to controls, concerning the (VLDL+LDL) frac-
tion (p<0.01). In concomitance, HDL-PC was descreased in CAD patients in
comparison with controls (p<0.05). Furthermore, serum PC level was colsely
correlated to waist/hip ratio only in CAD patients (p=0.0013). However, PC
concentrations were less closely associated to BMI in the same group
(p<0.035). 
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